Wordt geladen...
Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis
Management of Graves’ orbitopathy remains an important therapeutic challenge. Current therapeutic modalities are unsatisfactory in about one third of patients. Rituximab is a monoclonal antibody against CD20 antigen that is expressed in mature and immature B cells. Early experience with rituximab su...
Bewaard in:
| Gepubliceerd in: | Turk J Ophthalmol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Galenos Publishing
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5282540/ https://ncbi.nlm.nih.gov/pubmed/28182165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjo.26780 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|